Browse regulations

EU Exit regulation that revokes numerous EU-derived State Aid regulations, removes TFEU-based State Aid rights from domestic law, and revokes specific EU decisions on State Aid. It comes into force on IP completion day and contains three schedules making amendments to retained EU law, other legislation, and transitional provisions. The regulation eliminates EU-sourced State Aid rules including de minimis aid exemptions, block exemptions by sector, procedural regulations, and EU decisions such as those on coal mine closure aid and services of general economic interest.

These EU-derived State Aid rules represent precisely the kind of bureaucratic constraint that suppressed Britain's ability to pursue independent industrial and economic policy. The revocation of these regulations restores democratic sovereignty over subsidy decisions. While critics may warn of potential competitive distortions from unchecked state intervention, the proper response is transparency and democratic accountability, not retaining EU-derived constraints that were never subject to meaningful Parliamentary scrutiny. Post-Brexit Britain should design its own subsidy framework aligned with British interests, not maintain rules written in Brussels that prevented the UK from supporting strategically important sectors. The compliance costs and administrative burdens of these EU regulations served no democratic purpose.

These regulations amend EU-exit legislation on Supplementary Protection Certificates (SPCs) for plant protection products and medicinal products. They create separate definitions for GB and NI authorisations, replace UK-wide references with GB or NI equivalents, provide transition provisions for pre-Brexit authorisations, and ensure certificates don't lapse when a UK authorisation is replaced by separate GB and NI authorisations. The regulations adapt the existing SPC framework to the post-Brexit territorial landscape.

While SPCs represent a form of intellectual property monopoly extension, this regulation is a necessary technical amendment addressing the post-Brexit territorial split. Deletion would create legal ambiguity and undermine IP protection for pharmaceutical and plant protection innovations across GB and NI. Without these amendments, the SPC regime would be unworkable given the separate regulatory authorisations now required for Great Britain and Northern Ireland. The transition provisions and continuity guarantees prevent certificates from lapsing during the authorization replacement process, providing stability for innovators who relied on the previous UK-wide system.

Technical amendment to the 2019 Kimberley Process Certification Scheme Regulations, replacing references to 'exit day' (as defined in the EU Withdrawal Act 2018) with 'IP completion day' to ensure correct functioning of the legislation after Brexit. The Kimberley Process Certification Scheme is an international rough diamond certification scheme designed to prevent conflict diamonds from entering legitimate trade.

This is a purely technical amendment ensuring legal consistency after Brexit. The original 2019 Regulations established the UK's implementation of the Kimberley Process Certification Scheme, an international certification system that has operated successfully since 2003 with over 80 participating countries. Deleting this amendment would leave incorrect 'exit day' references in the 2019 Regulations, creating legal uncertainty. The KPCS itself imposes minimal bureaucratic burden—it is a market-based certification mechanism that diamond traders use voluntarily to access participating markets, not a command-and-control regulatory burden. Its costs fall on traders wishing to trade in rough diamonds internationally, and it achieves a legitimate public good (preventing conflict diamond trade) that markets alone would not achieve due to information asymmetries.

The Unauthorised Drilling Activities in the Eastern Mediterranean (Sanctions) (EU Exit) Regulations 2020 implement a sanctions regime targeting hydrocarbon exploration and production activities unauthorized by the Republic of Cyprus in its territorial sea, exclusive economic zone, or continental shelf. The regulations establish asset-freeze measures, director disqualification sanctions, immigration restrictions, and financial prohibitions against designated persons deemed 'involved' in such activities. They include provisions for Treasury licences, designation procedures (standard and urgent), and information-sharing requirements.

This sanctions regime imposes substantial compliance costs and criminal liability risks on financial institutions, energy companies, and service providers who may unknowingly engage with designated persons or activities. The 'involved person' definition is excessively broad, capturing those who merely provide 'support' or 'promotion' — potentially catching legitimate legal and financial services. The urgent designation procedure permits de facto asset-freezes without meeting standard evidence thresholds, with only a 56-day validation window. Such sector-specific economic sanctions restrict trade and investment in the Eastern Mediterranean energy sector, deter legitimate commerce, and create de-risking behavior among UK institutions that harms innocent counterparties. These costs are disproportionate to the policy goal, which could be better achieved through diplomatic channels rather than sweeping financial restrictions that mimic the very EU-style regulatory overreach this review process seeks to eliminate.

Post-Brexit amendment regulation that modifies the Nutrition (Amendment etc.) (EU Exit) Regulations 2019 to: (1) replace 'United Kingdom' references with 'Great Britain' or 'England and Wales and Scotland', (2) remove Northern Ireland provisions and transfer regulatory authority to Secretary of State/Scottish/Welsh Ministers, (3) add Water-Soluble Tomato Concentrate to permitted health claims, (4) modify infant formula and food for special medical purposes labelling requirements. Comes into force around IP completion day.

This regulation represents a continuation of the EU's heavy-handed pre-market authorisation regime for health claims, merely rebranding it with UK authorities instead of removing it. The health claim approval system restricts what food manufacturers can communicate about their products, suppressing commercial speech and reducing market competition. Adding specific health claims like Water-Soluble Tomato Concentrate through secondary legislation bypasses proper democratic scrutiny. The multi-layered authority structure (Secretary of State, Scottish Ministers, Welsh Ministers) adds complexity without justification. Rather than seizing Brexit's regulatory freedom to liberalise food labelling and health claims, this regulation preserves the EU's bureaucratic approach of government-approved messaging, restricting consumer information and impeding the food industry's ability to compete.

EU Exit statutory instrument amending the Medical Devices Regulations 2002 and related 2019 Regulations to ensure the UK medical devices regulatory framework functions after Brexit. Removes references to certain EU parts (VIII and IX), omits several paragraphs, and contains commencement provisions tied to IP completion day. Applies to Northern Ireland for certain provisions.

Deleting this regulation would create regulatory gaps and contradictions in the post-Brexit medical devices framework. Without these amendments, the 2002 Regulations would retain references to EU structures that no longer apply, potentially confusing manufacturers, delaying device approvals, and reducing supply to the NHS and patients. While technical, these amendments are necessary to maintain a functioning regulatory regime during Brexit transition - deleting them would harm Britons by creating compliance uncertainty and potentially restricting medical device availability.

This SI amends Council Regulation (EU) 2019/125 concerning trade in goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment. It replaces 'Union' references with 'United Kingdom', updates customs definitions to UK-specific legislation (Taxation (Cross-border Trade) Act 2018, Customs and Excise Management Act 1979), substitutes 'third country' with 'country or territory outside the United Kingdom', and removes EU institutional provisions (anti-torture coordination group, EU-level review mechanisms, penalties article). It preserves the core prohibitions on export, import, brokering services, training, advertising, and transit of torture goods while adapting them for post-Brexit UK.

Britons would be worse off if deleted because the UK would lose all legal authority to control trade in goods designed for capital punishment and torture. While this regulation restricts trade, it targets genuinely harmful commerce (torture equipment) that no free-trading nation should permit. The original EU regulation reflected universal ethical limits on commerce — Adam Smith's moral sentiments philosophy recognized such boundaries. The UK's Tariff and Export Control Order 2008 framework provides the enforcement mechanism. Deletion would create a regulatory vacuum where torture goods could freely flow through UK territory.

Commencement regulations bringing into force subsections (1) and (4) of section 44 of the Offensive Weapons Act 2019 for the purpose of inserting new subsection (3) (except paragraph (b)) and new subsections (6) to (8) into section 1 of the Restriction of Offensive Weapons Act 1959, which relate to defences to offences concerning dangerous knives.

As a commencement order, this regulation merely activates already-enacted statutory defences to dangerous knife offences. Without it, those defences would remain dormant under the 1959 Act, leaving individuals in England and Wales worse off by being unable to rely on defences Parliament has already legislated for. Deleting a commencement order does not repeal the underlying policy — it merely prevents the law from taking effect as intended.

Post-Brexit amendment to EU Regulation 2017/625 (Official Controls Regulation) that replaces EU institutional references (Member States, the Union, Commission) with UK authorities (Secretary of State, Welsh Ministers, Scottish Ministers) and geographic replacements (Great Britain, British Islands). Establishes the appropriate authority structure for England, Wales, and Scotland; defines 'third country' and 'Crown Dependency'; transfers regulatory powers from EU Commission to UK appropriate authorities; maintains border control posts, import inspection regimes, and official control frameworks for food, feed, animals, and plant health. Essentially a legal vehicle to make existing EU regulatory structures operable in the UK after Brexit.

This is a necessary Brexit technical amendment that transfers governing authority from EU institutions to UK authorities without fundamentally altering the regulatory structure. The underlying official controls regime (border inspections, food safety checks, plant health controls) addresses genuine externalities and information asymmetries in international trade that would persist regardless. While the controls add costs to imports, removing them would create food safety risks, trade disruptions, and public health hazards that would harm Britons. The amendment properly devolves authority to UK governments rather than centralising in Whitehall, which is consistent with constitutional propriety even if one might debate the underlying regulatory burden.

The Plant Health (Amendment etc.) (EU Exit) Regulations 2020 amend three sets of retained EU plant health regulations to reflect the UK's post-Brexit regulatory independence. Key changes include: replacing EU references with GB/UK equivalents; substituting EU directives (93/85/EEC, 98/57/EC, 2007/33/EC) with EPPO diagnostic standards (EPPO PM 7/21, PM 7/40, PM 7/59, PM 7/119); converting EU plant passports to UK plant passports; updating fee regulations; and restructuring official controls for plant health inspections. The regulations maintain biosecurity measures against harmful pests including Ralstonia solanacearum, Potato cyst nematodes, and Potato ring rot, while adapting the framework to UK-only governance.

Plant health regulations serve essential biosecurity functions that market mechanisms cannot self-organize. Without official controls preventing the introduction and spread of harmful plant pests, the agricultural and forestry sectors would face devastating economic losses from invasive species—losses that would ultimately be borne by consumers through higher prices and taxpayers through subsidy demands. While this regulation is largely a Brexit implementation text (replacing 'EU' with 'GB/UK'), the underlying plant health protection framework predates EU membership and exists in every country with a developed agricultural sector. The substitution of EU directives with EPPO international standards actually represents a move toward evidence-based standards rather than political ones. Deleting these controls would leave British agriculture and the natural environment vulnerable to pests for which eradication would be far more costly than prevention.

These Regulations extend the 'relevant period' for winding-up petitions under the Corporate Insolvency and Governance Act 2020 from 31 December 2020 to 31 March 2021, providing coronavirus-related protection for companies against creditor winding-up petitions in Great Britain.

This regulation merely postpones legitimate creditor enforcement actions without addressing underlying business viability. While COVID-19 was a genuine external shock, extending insolvency protections delays market correction of malinvested resources, perpetuates zombie companies, and harms creditors who cannot recover debts. The extension creates moral hazard by insulating management from consequences and signals that emergency interventions will keep being extended, undermining certainty and the rule of law. The March 2021 deadline it referenced would itself likely be extended further, as indeed occurred, demonstrating how such measures become permanent despite being framed as temporary.

Temporary COVID-19 regulations permitting expedited market access for coronavirus-related PPE before full conformity assessment and UK marking requirements were satisfied. Created pathways for CE/UK marked PPE to enter market via HSE assessment and notification to economic operators by specified dates (April/July 2021). Provided immunity from prosecution under the 2018 Regulations for non-compliance with Articles 8(2), 10(2), and 11(2) of the EU PPE Regulation. Applicable only to England.

These are explicitly temporary emergency regulations with built-in sunset dates (April and July 2021). As a post-Brexit regulatory reform agency focused on removing unnecessary retained EU laws, regulations that were designed to expire and have long since passed their expiry dates should be deleted. The regulations waive critical conformity assessment requirements and provide legal immunity for non-compliance with essential health and safety procedures — acceptable in a genuine emergency, but indefensible as permanent law. If PPE emergency provisions remain necessary, they should be replaced with targeted, time-limited legislation subject to proper parliamentary scrutiny, not carried forward as zombie regulations from the pandemic era.

This Order authorizes Network Rail to close multiple level crossings in Cambridgeshire and construct replacement highways, footpaths, bridleways and cycle tracks. It grants compulsory purchase powers, street works authority, and temporary land possession rights to facilitate the works. The Order repeals four older statutory instruments relating to level crossings and includes provisions for drainage, access creation, traffic regulation, and compensation for affected rights of way.

Level crossings represent genuine safety hazards causing deaths and infrastructure bottlenecks. While the planning regime requiring such elaborate enabling legislation reflects deeper systemic problems (NIMBYism, green belt rigidity), this specific Order merely facilitates a private infrastructure project with compensation protections. The safety benefits of consolidating railway crossings and providing proper alternative routes are substantial and hard to achieve through private negotiation alone given the compulsory purchase requirements. The regulation imposes minimal ongoing regulatory burden beyond the project lifecycle.

Post-Brexit amendment regulation making technical corrections to Product Safety and Metrology legislation. Schedule 3 corrects a cross-reference error (substituting 'toy' for 'regulated measuring instrument' in an inserted regulation). The Northern Ireland provisions in Schedule 6 modify cosmetic product enforcement provisions to reflect that certain England and Wales references no longer apply in NI. Schedules 13-14 amend measuring instrument regulations by replacing 'European Economic Area' references with 'relevant' and making related definitional adjustments for non-automatic weighing instruments. These are enabling amendments to ensure retained EU law functions correctly post-Brexit.

Deleting this regulation would leave the underlying Product Safety and Metrology framework with nonsensical EEA references that have been inapplicable since Brexit. The technical corrections enable rather than restrict trade by ensuring legal clarity and preventing enforcement chaos from contradictory cross-references. Without these amendments, businesses face uncertainty about which regulatory requirements actually apply. While the regulation makes minor technical changes, removing it would create more regulatory confusion, not less.

EU Exit statutory instrument that amends the Good Laboratory Practice Regulations 1999 and three other 2019 Brexit secondary legislation relating to human medicines and clinical trials. It removes certain EU-retained provisions and makes technical corrections for post-Brexit regulatory coherence.

While this regulation inherited EU law without proper Parliamentary scrutiny, deletion would create regulatory gaps in medicines safety, clinical trial authorization, and Good Laboratory Practice standards. The pharmaceutical sector requires regulatory continuity; removing these provisions risks creating legal uncertainty that would harm patients and industry alike. The amendments are largely technical corrections for legal coherence post-Brexit rather than new regulatory burdens.